A systematic review highlights the potential of genomic tests in prostate cancer treatment decisions but calls for more data ...

Inhibrx Biosciences, Inc. (Nasdaq: INBX) ("Inhibrx" or the "Company"), a clinical-stage biopharmaceutical company focused on developing therapeutics for oncology and rare diseases, today announced ...

Kudos to Authors of New ICCPUD Alcohol Intake & Health Study SAN RAFAEL, Calif., Jan. 21, 2025 /PRNewswire/ -- Alcohol Justice is rep ...

Stuart Therapeutics, Inc. (Stuart), a clinical-stage drug platform company developing novel therapies for ophthalmic diseases, today announced last patient last visit in the phase III study of its ...

Is your waistline growing? So are the dangers! A bigger waist circumference (WC) increases the risk of diabetes, metabolic ...

As AI continues to evolve at an unprecedented pace, with breakthroughs in generative models, ethical guidelines, and applications across various sectors, the question is often asked — how will these ...

How immunity evolves over time? Children may require immunotherapies designed to kickstart their immune cells to kill tumor ...

Today, the Barbara Ann Karmanos Cancer Institute, part of McLaren Health Care, cut the ribbon at the new Karmanos Cancer Institute – Dearb ...

Improve memory and cognitive health with 2-minute daily exercises like deep breathing, visualization, and memory flashbacks.

Discover how Maha Kumbh 2025 integrates world-class healthcare with advanced services, including free eye care and AI tools, ...

Raise awareness this January about glaucoma-a silent cause of blindness-with early detection and proactive care.

Old viral DNA, once thought to be gone forever, is reactivated in mammalian embryos, with each species showing unique ...